APA (7th ed.) Citation

MB, G., FR, B., MC, S., LM, M., M, S., TR, S., . . . NA, C. (2026). Distinctive features of cancer-associated fibroblasts expressing CD105, a novel biomarker for bone metastasis, in early-stage invasive ductal breast cancer. Frontiers in endocrinology, 17, 1766643. https://doi.org/10.3389/fendo.2026.1766643

Chicago Style (17th ed.) Citation

MB, Giorello, Borzone FR, Sanmartin MC, Martinez LM, Sarkar M, Sarkar TR, Labovsky V, Wernicke A, and Chasseing NA. "Distinctive Features of Cancer-associated Fibroblasts Expressing CD105, a Novel Biomarker for Bone Metastasis, in Early-stage Invasive Ductal Breast Cancer." Frontiers in Endocrinology 17 (2026): 1766643. https://doi.org/10.3389/fendo.2026.1766643.

MLA (9th ed.) Citation

MB, Giorello, et al. "Distinctive Features of Cancer-associated Fibroblasts Expressing CD105, a Novel Biomarker for Bone Metastasis, in Early-stage Invasive Ductal Breast Cancer." Frontiers in Endocrinology, vol. 17, 2026, p. 1766643, https://doi.org/10.3389/fendo.2026.1766643.